In the constantly evolving field of pharmaceutical manufacturing, the imperative to embrace new technologies and innovative strategies for process control and efficiency is more pressing than ever before.
Recent advancements in aseptic processing, such as advanced isolators, robotics, and increased automation, have transformed the industry whilst simultaneously reducing the risks of contamination for sterile products. However, modern therapies - innovative, targeted treatments that result in small-batch aseptic products - require faster speeds to market and present unique sterilization and handling challenges. This dichotomy presents unique challenges for the industry to address.
Moreover, the updated Annex 1 is impacting the manufacturing of sterile products, necessitating updated requirements such as Quality Risk Management, Contamination Control Strategy, and Data Management and Compliance for Computerized Systems.
In light of these urgent needs, the 2024 ISPE Aseptic Conference will provide an ideal opportunity for participants to share progress, success stories, best practices, and lessons learned. Get ahead of the game with a focus on novel therapies, emerging technologies, and aseptic processing. We look forward to seeing you in Vienna, Austria!